FDA Investigator Lauren E Swantko

Lauren E Swantko has inspections in 9 countries as of 31 Oct 2023. Lauren E Swantko has collaborated with a combinined 2948 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
31 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Ireland, United States of America, Poland, Italy, Canada, Ukraine, India, Serbia, United Kingdom of Great Britain and Northern Ireland
Aaron J Poloni, Abigail A Andersen, Adamsr, Alan D Grupe, Aleta T Flores, Alexander M Kay, Alicia A Borg Borm, Anita Narula, PhD, Anthony E Keller, RPh, Arie R Dyk, Ava M Bowman, Barbara Janine Breithaupt, Belinda E Clifton, Beverly A Thomas, Brenda K Alford, Bruce R Burrell, Bryan Baker, Bryce E Mansfield, Celeta S Coves, Celia L Hutchinstein, Celia L Silverstein, Christina L Norton, Christopher R Czajka, Clinton R Vanblaricom, Connie P Rezendes, Dan G Eisenbrey, Dawn E Barkans, Deborah Kleinfeld, Dennis G Kawabata, Dennis M Farley, Dennis R Hudson, Diane Hall, Dianna D Wardlow Dotter, Dianne B Latona, Dipti Kalra, Dolores E Price, Don A Leeseberg, Donald W Jehn, Dustin P Tran, Elizabeth E Hart (ASCP), MT, Elizabeth S Howell, Emily B Camire, Eric C Milstead, Eric L Scott, Eric T Huebler, Farhana Khan, Gabriel M Guevarra, Garrad R Poole, Gavin W Pierce, Gerard Pde Leon, Gina C Collins, Gloria A Milster, Gloria J Baca, MS, Haley H Seymour, Harmon M Blanch, Herbert Arden, Herbert E Arden, Hugh Grimoldby, Hugh M Mcclure, II, Ismael Olvera, IV, Jacob N Hamilton, James A Lane, James D Eildreth, James D Hildreth, James H Robinson, Jean Brewer, Jeanne M Weishaar, Jeffrey J Leclair, Jessica B Clark, Jessica L Walters Moell, Jessie J Deloach, Jinkee Mvila Binayug, John A Iwen, John W Banks, Jonathan T Little, Joseph A Seitz, Julian C Hanson, Ka L Wong, Kaitlyn R Kornberg, Karen M Montgomery (KMM), Katherine L Arnold, Kathryn A Krentz, Kellie L Westerbuhr, Kelsey A Hustedt, Kimberly J Proctor Jones, Kip J Hanks, Lakecha N Lewis, Lance M De Souza, MBA, Lance W Bohm, Laurissa S Flowers, Laverne Puckett, Lawrence Y Lee, PhD, LCDR Margaret E Digennaro, Leeterry Moore, Lesley A Swanson, Lester O Boian, Leya A Grosch, Lisa K Capron, Lisa M Althar, Lori J Silverstein, LTJG Bradley E Benasutti, Maida Henesian (NMI), Marc A Jackson, Jr, Marcus A Goshen, Margo Cl Jones, Maria Pkelly Doggett, MBA, Mark E Imsland, Mark W Babbitt, Marlene L Davis, Mary Ewilkerson Brinsko, Mary T Carden, Matthew J Gretkierewicz, Melissa D Kalik, Michael F Schuette, Michael I Gorman, Michael J Donovan, Michael S Hudson, Minh D Phan, Mpris Inspector, Narahi J Alvarez Alcazar, Neil J Traaen, Peter Kessler, PhD, Peter T Regan, Rachel J Cantrell, Randy L Elsberry, Raymond W Brullo, Rebecca A Sletner, Rebecca T Davis, Richard J Bashay, Richard T Riggie, Robert A Williams, Robert S Sweeton, Rocco C Black, S Lori Brown, PhD MPH, Sandra S Saniga, Savini, Scott Reynolds, Shannon J Hall, Shelagh D Schopen, Shelley H Beausoleil, Shelley H Roberts, Sherri N Rohlf, MD, Stacy A Schneider, State Agency, Stephanie A Slater, MS, Stephen R Souza, Stephen T Hansen, Stuart W Russell, Sunitha K Rajaram, PhD, Sunny R Muir, Tania Y Hall, Thomas C Mclean, CFS, Timothy P Lafave, Travis S Bradley, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Vining, Vitaliy N Guyvan, William A Burkey, William J Foust, Williamsra, Young M Yoon, Yvonne C Wilkes, Zachary P Wachlarowicz

Lauren E Swantko's Documents

Publish Date Document Type Title
January, 2013 FDA 483 Boise VAMC - Form 483, 2013-01-24
July, 2015 EIR David A. Evans, M.D. - EIR, 2015-07-22
July, 2012 EIR Xtant Medical Holdings Inc - EIR, 2012-07-26
April, 2012 FDA 483 Response Biomat USA, Inc. - Form 483R, 2012-05-09
July, 2015 FDA 483 David A. Evans, M.D. - Form 483, 2015-07-22
January, 2013 EIR Boise VAMC - EIR, 2013-01-24
July, 2012 FDA 483 Xtant Medical Holdings Inc - Form 483, 2012-07-26
July, 2018 FDA 483 Olukemi Wallace - Form 483, 2018-07-13

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more